» Articles » PMID: 1314587

Cloning and Pharmacological Characterization of a Human Bradykinin (BK-2) Receptor

Overview
Publisher Elsevier
Specialty Biochemistry
Date 1992 Apr 15
PMID 1314587
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

A human BK-2 bradykinin receptor was cloned from the lung fibroblast cell line CCD-16Lu. The cDNA clone encodes a 364 amino acid protein that has the characteristics of a seven transmembrane domain G-protein coupled receptor. The predicted amino acid sequence of the human BK-2 receptor is 81% identical to the smooth muscle rat BK-2 receptor (1). Transfection of the human BK-2 receptor cDNA into COS-7 cells results in the expression of high levels of specific BK binding sites. Saturation binding analysis indicates that the human BK-2 receptor expressed in COS-7 cells binds BK with a KD of 0.13 nM. Pharmacological characterization of the expressed BK receptor is consistent with the cDNA encoding a receptor of the BK-2 subtype. The BK-2 receptor antagonist Hoe 140 (2), D-Arg0[Hyp3, Thi5, D-Tic7, Oic8]BK has a high affinity (IC50 = 65 pM) for the cloned human receptor. The tissue distribution of the human BK-2 receptor was analyzed by competitive PCR with human tissue cDNA and is similar to that determined for the BK-2 receptor in the rat.

Citing Articles

A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases.

Rex D, Vaid N, Deepak K, Dagamajalu S, Keshava Prasad T Mol Biol Rep. 2022; 49(10):9915-9927.

PMID: 35596055 PMC: 9122735. DOI: 10.1007/s11033-022-07539-2.


Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.

Nokkari A, Abou-El-Hassan H, Mechref Y, Mondello S, Kindy M, Jaffa A Prog Neurobiol. 2018; 165-167:26-50.

PMID: 29355711 PMC: 6026079. DOI: 10.1016/j.pneurobio.2018.01.003.


The molecular basis of subtype selectivity of human kinin G-protein-coupled receptors.

Joedicke L, Mao J, Kuenze G, Reinhart C, Kalavacherla T, Jonker H Nat Chem Biol. 2018; 14(3):284-290.

PMID: 29334381 PMC: 7992120. DOI: 10.1038/nchembio.2551.


Evidence and evidence gaps of medical treatment of non-tumorous diseases of the head and neck.

Bas M GMS Curr Top Otorhinolaryngol Head Neck Surg. 2016; 15:Doc02.

PMID: 28025602 PMC: 5169075. DOI: 10.3205/cto000129.


Dynorphin A analogs for the treatment of chronic neuropathic pain.

Hall S, Lee Y, Hruby V Future Med Chem. 2016; 8(2):165-77.

PMID: 26824470 PMC: 4976860. DOI: 10.4155/fmc.15.164.